Results 181 to 190 of about 8,311 (216)

Treatment of Waldenstrom's Macroglobulinemia with Nucleoside Analogues

Leukemia and Lymphoma, 1993
Hagop Kantarjian, Susan O'Brien, R Alexanian   +2 more
exaly  

Waldenstrom’s Macroglobulinemia

2013
Larry C. Daugherty, Brandon J. Fisher, Jo Ann Chalal, Lindsay G. Jensen, Loren K. Mell, Johannes Classen, Patrizia Guerrieri, Paolo Montemaggi, Christin A. Knowlton, Michelle Kolton Mackay, David E. Wazer, Larry C. Daugherty, Brandon J. Fisher, Larry C. Daugherty, Brandon J. Fisher, Larry C. Daugherty, Brandon J. Fisher   +16 more
openaire   +1 more source

Waldenstrom Macroglobulinemia

2017
Meghan E. Kapp, Gisella Vischini, Agnes B. Fogo   +2 more
openaire   +1 more source

The International Staging System for Multiple Myeloma is Applicable in Symptomatic Waldenstrom's Macroglobulinemia

Leukemia and Lymphoma, 2004
Athanasios Anagnostopoulos, Meletios Dimopoulos, Argiris Symeonidis   +2 more
exaly  

Cryptococcal Meningitis and Intracranial Tuberculoma in a Patient with Waldenstrom's Macroglobulinemia Treated with Fludarabine

Leukemia and Lymphoma, 1998
Roberto Luzzati, Pier Luigi Zinzani, E Aitini   +2 more
exaly  

Waldenstrom's Macroglobulinemia

2008
Lijo Simpson, Morie Gertz
openaire   +1 more source

TREATMENT OF RESISTANT WALDENSTROM'S MACROGLOBULINEMIA WITH HIGH DOSE GLUCOCORTICOSTEROIDS

Australian and New Zealand Journal of Medicine, 1988
H H Salem, S M Jane
exaly  

Temporal and geographic variations of Waldenstrom macroglobulinemia incidence

Cancer, 2012
Jia-Lei Wang, Michael Wang, Larry Kwak
exaly  

Serum immunoglobulin free light chain correlates with tumor burden markers in Waldenstrom macroglobulinemia

Leukemia and Lymphoma, 2008
Steven P. Treon, Nicholas Burwick, Valerie Coiteux   +2 more
exaly  

The current role of BTK inhibitors in the treatment of Waldenstrom’s Macroglobulinemia

Expert Review of Anticancer Therapy, 2020
Meletios Dimopoulos, Despina Fotiou, Maria Gavriatopoulou   +2 more
exaly